The aim of this study and systematic review is to evaluate the clinicopathologic features of patients with MMR-intact, MLH1 methylation positive, MMR-deficient and Lynch syndrome endometrial cancers in order to better understand this expanding population. Here, MLH1 is linked to endometrial cancer.